Natarajan Sethuraman
President, Research & Develop., Entrada Therapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$0.4M
Companies
1
Latest trade
May 4, 2026
Companies
Entrada Therapeutics, Inc.President, Research & Develop. −$0.4M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.